Tag: biosimilar coding
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Categories
Medications
Archives
Recent-posts
Foreign Manufacturing of Generics: FDA Oversight and Standards in 2025
Dec, 17 2025
Bronchial Asthma vs COPD: Key Differences Explained
Oct, 6 2025
Natural Ways to Prevent and Treat Cold Sores Fast
Oct, 13 2025
Reimbursement and Coding for Biosimilars: How Billing Works Under Medicare Part B
Feb, 25 2026
2025 Alternatives for Prelone: A Practical Guide
Feb, 28 2025